Chanshuai Han

Chanshuai Han

Auto-generated profile, based on publicly available information

Chanshuai Han

The Neuro’s Early Drug Discovery Unit (EDDU), McGill University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2012 in AGE
Verified
Journal Article
Closed access
PDF file
ZTZhiqian Tong
Zhiqian Tong
CHChanshuai Han
Chanshuai Han
WLWenhong Luo
Wenhong Luo
XWXiaohui Wang
Xiaohui Wang
HLHui Li
Hui Li
RHRongqiao He
Rongqiao He

1 January 2015 in Neurobiology of Aging
Verified
Journal Article
Closed access
ZTZhiqian Tong
Zhiqian Tong
CHChanshuai Han
Chanshuai Han
MQMin Qiang
Min Qiang
WWWeishan Wang
Weishan Wang
JLJihui Lv
Jihui Lv
RHRongqiao He
Rongqiao He

11 June 2015 in Aging Cell
Verified
Journal Article
Open access
PDF file
YWYan Wei
Yan Wei
CHChanshuai Han
Chanshuai Han
YWYujing Wang
Yujing Wang
BWBeibei Wu
Beibei Wu
TSTao Su
Tao Su
RHRongqiao He
Rongqiao He
Summary: Type 2 diabetes mellitus (T2DM) is regarded as one of the serious risk factors for age‐related cognitive impairment; however, a causal link between these two diseases has so far not been established. It was recently discovered that, apart from high D‐glucose levels, T2DM patients also display abnormally high concentrations of uric D‐ribose. Here, we show for the first time that the administration of D‐ribose, the most active glycator among monosaccharides, produces high levels of advanced glycation end products (AGEs) and, importantly, triggers hyperphosphorylation of Tau in the brain of C57BL/6 mouse and neuroblastoma N2a cells. However, the administration of D‐glucose showed no significant changes in Tau phosphorylation under the same experimental conditions. Crucially, suppression of AGE formation using an AGEs inhibitor (aminoguanidine) effectively prevents hyperphosphorylation of Tau protein. Further study shows AGEs resulted from ribosylation activate calcium‐/calmodulin‐dependent protein kinase type II (CaMKII), a key kinase responsible for Tau hyperphosphorylation. These data suggest that there is indeed a mechanistic link between ribosylation and Tau hyperphosphorylation. Targeting ribosylation by inhibiting AGE formation may be a promising therapeutic strategy to prevent Alzheimer's disease‐like Tau hyperphosphorylation and diabetic encephalopathies.

13 March 2014 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
CHC Han
C Han
YLY Lu
Y Lu
Wei YanWei Yan
Wei Yan
BWB Wu
B Wu
YLY Liu
Y Liu
RHR He
R He
Non-enzymatic glycation of proteins by reducing saccharides for instance D-glucose is an important post-translational modification regulating protein function. Already two centuries ago, D-glucose (Glc) was identified in the urine of diabetic patients. Recently, abnormally high level of D-ribose (Rib) in the urine of type 2 diabetics has been discovered, which is highly active in protein glycation, resulting in the production of advanced glycation end products (AGEs). Accumulation of AGEs leads to altered cellular function, for example AGE accumulation in the nervous system impairs cognitive ability, yet the mechanisms mediating this process for Rib are unknown. Here we found that treatment with Rib accelerated AGE formation in U251 and U87MG astrocytoma cells and in mouse brain, inducing upregulation of receptor for AGEs (RAGE). Astrocytoma cells with elevated levels of RAGE displayed enhanced activity of the proinflammatory nuclear transcription factor kappaB and increased expression of tumor necrosis factor alpha and glial fibrillary acidic protein. Moreover, injection of Rib induced astrocyte activation in mouse hippocampus and impaired spatial learning and memory abilities. These results indicate that mouse spatial cognitive impairment caused by Rib-derived AGEs is correlated with activation of an astrocyte-mediated, RAGE-dependent inflammatory response. This study may provide insights into the mechanism of Rib-involved cognitive impairments and diabetic encephalopathy.

1 December 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CHChanshuai Han
Chanshuai Han
RAReem Alkhater
Reem Alkhater
TFTawfiq Froukh
Tawfiq Froukh
AMArakel G. Minassian
Arakel G. Minassian
MGMelissa Galati
Melissa Galati
PMPeter S. McPherson
Peter S. McPherson

3 April 2014 in Protein & Cell
Verified
Journal Article
Open access
PDF file
MQMin Qiang
Min Qiang
YXYajie Xu
Yajie Xu
YLYang Lu
Yang Lu
YHYingge He
Yingge He
CHChanshuai Han
Chanshuai Han
RHRongqiao He
Rongqiao He